Stay updated on Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the notice about a lapse in government funding and operating-status details was removed (the prior notice was v3.4.1).
    Difference
    0.9%
    Check dated 2026-02-11T10:28:20.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page version was updated from v3.4.0 to v3.4.1 and a site-wide notice about potential data delays due to a lapse in government funding was added.
    Difference
    0.9%
    Check dated 2026-02-04T05:58:07.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    UI and versioning updates include showing the glossary, color-coded highlights, and a new revision label (v3.4.0). These changes do not modify core study data or critical information.
    Difference
    1%
    Check dated 2026-01-28T03:25:12.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A new history revision v3.3.4 was added to the history and the previous revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:38:18.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added a new revision entry 'Revision: v3.3.3' to the Record History, and removed the 'HHS Vulnerability Disclosure' link along with the 'Revision: v3.3.2' entry from the footer.
    Difference
    0.2%
    Check dated 2025-12-23T10:22:04.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.3.1 was removed in the page history, indicating a minor site version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:31:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.